JACK NATHAN MEDICAL CORP (JNH.CA) Stock Income Statement
TSX-V:JNH - TSX Venture Exchange - CA4663771083 - Common Stock - Currency: CAD
| TTM (2024-10-31) | 2024 (2024-1-31) | 2023 (2023-1-31) | 2022 (2022-1-31) | 2021 (2021-1-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 26.61M | 19.14M | 15.49M | 9.64M | 3.85M | |||
| Minority Interest Expense | N/A | N/A | 0.00 | 208.30K | 11.00K | |||
| Operating Expenses | 35.29M | 24.47M | 20.79M | 16.55M | 5.11M | |||
| Research and Development | N/A | N/A | 236.90K | 546.10K | 102.00K | |||
| Selling, General, and Administrative Expenses | 33.76M | 23.29M | 19.48M | 15.49M | 4.86M | |||
| Operating Income | -8.68M | -5.32M | -5.30M | -6.91M | -1.26M | |||
| Interest Income/Expense | -627.00K | -1.10M | -190.20K | -199.00K | -210.70K | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | -72.80K | |||
| Non Recurring Items | 316.00K | -1.03M | -1.50M | -1.12M | -8.76M | |||
| Income Before Taxes | -11.06M | -7.44M | -6.99M | -8.23M | -10.29M | |||
| Income Tax | -720.60K | -805.80K | -86.00K | -217.50K | -380.90K | |||
| Net Income | -10.34M | -6.64M | -6.90M | -7.81M | -9.90M | |||
| EBITDA | -7.39M | -4.14M | -4.23M | -6.40M | -1.11M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.12 | -0.08 | -0.08 | -0.10 | -0.19 | |||
| Statistics | ||||||||
| Profit Margin | -38.86% | -34.66% | -44.57% | -81.00% | -257.05% | |||
| Operating Profit Margin | -32.62% | -27.79% | -34.23% | -71.71% | -32.58% | |||
All data in CAD